Cargando…

Response to the Letter to the Editor ‘Reply to “Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study” by Dr. Peng Chen’

Detalles Bibliográficos
Autores principales:	Yamao, Kentaro, Watanabe, Tomohiro, Kudo, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2019
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118373/ https://www.ncbi.nlm.nih.gov/pubmed/31735800 http://dx.doi.org/10.2169/internalmedicine.3958-19

Ejemplares similares

Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study
por: Yamao, Kentaro, et al.
Publicado: (2019)

Pegylated G-CSF Combined with mFOLFIRINOX for Advanced Pancreatic Cancer Patients
por: Chen, Peng, et al.
Publicado: (2019)

Efficacy and safety of SOXIRI versus mFOLFIRINOX in advanced pancreatic cancer
por: Li, Xujia, et al.
Publicado: (2023)

Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer
por: Shen, Feifei, et al.
Publicado: (2022)

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial
por: van Dam, J. L., et al.
Publicado: (2023)

Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S‐1 as second‐line chemotherapy in metastatic pancreatic cancer
por: Ikezawa, Kenji, et al.
Publicado: (2021)

The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective study
por: Yang, Lei, et al.
Publicado: (2023)

Reply to Chen and Vitetta
por: Violi, Francesco, et al.
Publicado: (2022)

Reply to Chen et al.
por: Hedner, Jan, et al.
Publicado: (2022)

Reply to Chen et al.
por: Chen, Zhanghua, et al.
Publicado: (2022)

Reply to Chen et al.
por: Zamarrón, Ester, et al.
Publicado: (2023)

Reply to Chen et al.
por: Solelhac, Geoffroy, et al.
Publicado: (2023)

Real World First-Line Treatments and Outcomes of Nab-Paclitaxel Plus Gemcitabine, mFOLFIRINOX and GEMOX in Unresectable Pancreatic Cancer from a Chinese Single Institution
por: Quan, Qi, et al.
Publicado: (2020)

Dr. Haxby's Reply to the Editors
por: Haxby, John
Publicado: (1815)

Reply to Peng et al.: Chicken tessellation requires more pieces
por: Peters, Joris, et al.
Publicado: (2022)

Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948)
por: Bouchahda, Mohamed, et al.
Publicado: (2023)

An obituary of Dr. Ding-Shinn Chen
Publicado: (2020)

Reply to the Letter to the Editor by Dr. Chirumbolo
por: Won, Dong Il
Publicado: (2016)

Reply to Peng and Zhao: Loss of endocytic protein TOM1 in Alzheimer’s disease
por: Martini, Alessandra C., et al.
Publicado: (2020)

Letter to the Editor in response to Chen et al. 2020
por: Ponnampalam, Jaya, et al.
Publicado: (2020)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Details in the evaluation of circular RNA detection tools: Reply to Chen and Chuang
por: Zeng, Xiangxiang, et al.
Publicado: (2019)

Reply to Dr. de Kernagal’s Letter to the Editor “FAST and undertriage”
por: Lubbers, Wouter D., et al.
Publicado: (2010)

Selected works of Peng Huan-Wu
por: Beijing Univ. Beihing. Institute of Theoretical Physics
Publicado: (1985)

Can Localized Stenosis of the Main Pancreatic Duct be a Predictive Factor for Early Detection of Pancreatic Cancer?
por: Takenaka, Mamoru, et al.
Publicado: (2019)

G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans
por: Cardot-Ruffino, Victoire, et al.
Publicado: (2023)

Integrative taxonomic analyses reveal first country records of Occidozygashiwandashanensis Chen, Peng, Liu, Huang, Liao & Mo, 2022 and Hylaranalatouchii (Boulenger, 1899) (Anura, Dicroglossidae, Ranidae) from Vietnam
por: Tran, Tung Thanh, et al.
Publicado: (2023)

Reply to “Concerns about Transmission Electron Micrographs in Recent Article by Chen and Williams”
por: Neal Williams, Henry
Publicado: (2012)

Reply to Chen et al.: Network Analysis Subtleties in ICU Structures and Outcomes
por: Costa, Deena Kelly, et al.
Publicado: (2020)

Reply to Dr. Tourtier’s Letter to the Editor “Human errors in (inhuman?) triage”
por: Giannakopoulos, Georgios F., et al.
Publicado: (2010)

PENG block: Advantages of out-of-plane approach
por: Lopez-Lopez, David, et al.
Publicado: (2021)

Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
por: Bouchart, Christelle, et al.
Publicado: (2023)

Editor's Reply
por: Veitch, Emma
Publicado: (2005)

Editors' Reply
por: Barbour, Virginia, et al.
Publicado: (2005)

Editors' Reply
por: Barbour, Virginia, et al.
Publicado: (2005)

Editors' reply
por: Jain, Anil Kumar
Publicado: (2008)

Reply to the editor
por: Hasan, Ali A., et al.
Publicado: (2014)

Reply to the editor
por: Al Otair, Hadil AK
Publicado: (2014)

Reply to the editor
por: Faverio, Paola
Publicado: (2014)

Reply to the editor
por: Al-Jahdali, Hamdan
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jle655jt4j42htg748tr2ecr9k